Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep542 | Diabetes therapy | ECE2016

Add on exenatide treatment in obese type 2 diabetic patients under intensive insulin regiments

Sonmez Alper , Dinc Mustafa , Taslipinar Abdullah , Aydogdu Aydogan , Meric Coskun , Basaran Yalcin , Haymana Cem , Demir Orhan , Azal Omer

Introduction: Intensive insulin treatment in obese patients with type 2 diabetes (T2DM) is often difficult. Insulin dosages are much higher, which further increase weight gain and the risk of hypoglycemia. Glucagon like peptide 1 receptor agonists (GLP-1RAs) are the promising treatment modalities causing weight loss and reducing the risk of hypoglycemia. There is no published data about the effect of adding on GLP1RAs to obese T2DM patients with un-controlled glucose levels un...

ea0056p962 | Male Reproduction | ECE2018

Hematological indices in congenital hypogonadism and the effect of testosterone replacement therapy: A retrospective study

Haymana Cem , Demirci Ibrahim , Dinc Mustafa , Demir Orhan , Akin Onur , Meric Coskun , Aydogdu Aydogan , Sonmez Alper , Azal Omer

Introduction: Patients with hypogonadism are at increased risk for cardiovascular diseases. Mean platelet volume (MPV), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) are hematological indices that are surrogate markers of adverse cardiovascular outcomes. This study investigated the platelet count, MPV levels, PLR, and NLR in patients with congenital hypogonadotrophic hypogonadism (CHH) and also studied the effect of testosterone replacement thera...

ea0049ep1165 | Male Reproduction | ECE2017

Endothelial dysfunction, inflammation and insulin resistance in patients with Klinefelter Syndrome

Haymana Cem , Aydogdu Aydogan , Demirci Ibrahim , Dinc Mustafa , Demir Orhan , Torun Deniz , Yesildal Fatih , Meric Coskun , Basaran Yalcin , Sonmez Alper , Azal Omer

Introduction: The prevalence of cardiometabolic disorders such as type 2 diabetes mellitus, dysipidemia and metabolic syndrome is increased in patients with Klinefelter syndrome (KS). The mechanism by which cardiometabolic risk increases in patients with KS remains to be completely elucidated. We investigated the presence of inflammation, insulin resistance and endothelial dysfunction in an unconfounded population of KS.Methods: A total of 31 patients wi...

ea0041ep716 | Male Reproduction | ECE2016

The investigation of oxidative stress-related parameters in congenital hypogonadism

Haymana Cem , Aydogdu Aydogan , Soykut Bugra , Erdem Onur , Ibrahimov Tural , Dinc Mustafa , Meric Coskun , Taslipinar Abdullah , Basaran Yalcin , Sonmez Alper , Azal Omer

Introduction: Patients with hypogonadism are at increased risk of cardiac and metabolic diseases. The pathogenesis of increased cardio-metabolic risk in hypogonadal patients is not clear. Oxidative stress plays an important role in the pathogenesis of cardio-metabolic diseases. The aim of this study was to search for any difference of the oxidative stress parameters between in patients with hypogonadism and healthy controls.Materials and Methods: Thirty ...

ea0041ep1087 | Thyroid cancer | ECE2016

Comparisons of Endothelial Dysfunction, Inflammation and Insulin Resistance in Differentiated Thyroid Cancer Patients According to Their Radioactive Iodine Treatment Status

Dinc Mustafa , Baskoy Kamil , Yildiz Ramazan , Tapan Serkan , Alagoz Engin , Yesildal Fatih , Ozturk Erkan , Taslipinar Abdullah , Aydogdu Aydogan , Deveci Salih , Arslan Nuri , Azal Omer , Sonmez Alper

Objective: Radioactive iodine (RAI) treatment has been reported to be associated to increased cardiovascular events and death compared to the general population, but the mechanism is not fully understood. Endothelial dysfunction, inflammation, and insulin resistance play important roles in the pathogenesis of atherosclerotic events. We aimed to compare papillary thyroid carcinoma patients receiving levothyroxine suppression therapy after bilateral total thyroidectomy with or w...

ea0056gp89 | Diabetes Epidemiology | ECE2018

Depression screening in adults with diabetes

Demirci Ibrahim , Haymana Cem , Sonmez Yusuf Alper , Bolu Abdullah , Kirnap Nazli Gulsoy , Demir Orhan , Dinc Mustafa , Meric Coskun , Aydogdu Aydogan , Azal Omer

Introduction: Elevated depressive symptoms and depressive disorders affect one in four patients with type 1 or type 2 diabetes (1). Thus, routine screening for depressive symptoms is indicated in this high-risk population. Current guidelines all recommend screening for depression in diabetic population(2). The Patient Health Questionnaire-9 (PHQ-9) is a valid screening tool for depression in individuals with diabetes (3). There is no specific data about the prevalence of depre...